These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31619209)

  • 1. Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series.
    Torti C; Mazzitelli M; Longhini F; Garofalo E; Bruni A; Giancotti A; Barreca GS; Quirino A; Liberto MC; Serapide F; Matera G; Trecarichi EM; Navalesi P;
    BMC Infect Dis; 2019 Oct; 19(1):858. PubMed ID: 31619209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
    Härter G; Zimmermann O; Maier L; Schubert A; Mertens T; Kern P; Wöhrle J
    Clin Infect Dis; 2010 May; 50(9):1249-51. PubMed ID: 20367227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.
    Turner DA; Rehder KJ; Peterson-Carmichael SL; Ozment CP; Al-Hegelan MS; Williford WL; Peters MA; Noble PW; Cheifetz IM
    Respir Care; 2011 Jul; 56(7):941-6. PubMed ID: 21352668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
    Chan-Tack KM; Kim C; Moruf A; Birnkrant DB
    Antivir Ther; 2015; 20(5):561-4. PubMed ID: 25667992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency.
    Pichon M; Picard C; Simon B; Gaymard A; Renard C; Massenavette B; Malcus C; Monneret G; Morfin-Sherpa F; Valette M; Javouhey E; Millat G; Lina B; Josset L; Escuret V
    Antiviral Res; 2018 Dec; 160():1-9. PubMed ID: 30315875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
    Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
    Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11-2012/13.
    Streng A; Prifert C; Weissbrich B; Liese JG;
    BMC Infect Dis; 2015 Dec; 15():573. PubMed ID: 26678835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A H1N1 pdm09-associated myocarditis during zanamivir therapy.
    Ito N; Sato M; Momoi N; Aoyagi Y; Endo K; Chishiki M; Kawasaki Y; Hosoya M
    Pediatr Int; 2015 Dec; 57(6):1172-4. PubMed ID: 26482326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient control of pandemic 2009 H1N1 virus infection with intravenous zanamivir despite the lack of immune function.
    Ghosh S; Adams O; Schuster FR; Borkhardt A; Meisel R
    Transpl Infect Dis; 2012 Dec; 14(6):657-9. PubMed ID: 23013415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet digital PCR to investigate quasi-species at codons 119 and 275 of the A(H1N1)pdm09 neuraminidase during zanamivir and oseltamivir therapies.
    Abed Y; Carbonneau J; L'Huillier AG; Kaiser L; Boivin G
    J Med Virol; 2017 Apr; 89(4):737-741. PubMed ID: 27602879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
    Bal A; Casalegno JS; Melenotte C; Daviet F; Ninove L; Edouard S; Morfin F; Valette M; De Lamballerie X; Lina B; Papazian L; Nougairède A; Hraiech S
    Clin Microbiol Infect; 2020 Jul; 26(7):947.e1-947.e4. PubMed ID: 32205296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.